COMMBIO THERAPEUTICS

Scientific research continues to provide evidence that many diseases' are modulated by signals/targets from within the gut. Our approach at CommBio is to integrate disease-curing-genes into the chromosome of gut bacteria using synthetic biology tools, such that these bacteria can accurately deliver disease modulating signals as they pass through the human gut. We believe that this modality has great potential to become a breakthrough therapy for specific types of diseases. As of now, programs in our pipeline target a broad range of indications including metabolic, autoimmune, neurodegenerative diseases, and cancer. Along-side our drug pipeline, we have also designed bacteria based products that address daily health needs such as alcohol metabolism that prevent hangovers as well as associated toxicities, and products that assist weight loss, which we plan to develop as consumer products... CommBio was founded in Zhangjiang Pharma Valley, Shanghai, China in 2019 by two experienced..

Also known as: CommBio, CommBio Therapeutics Co., Ltd

Primary location: Shanghai China